Investor Profile: Beringea — Thesis, Cheque Size & How to Apply

Finding Beringea funding means tapping a transatlantic venture firm built to help companies scale across the US and the UK. Founded in 1988, Beringea runs offices in Detroit (Farmington Hills) and London, managing roughly $900m across its funds on both sides of the Atlantic. In the UK it is best known as the long-standing manager of the ProVen Venture Capital Trusts — two of the country's largest and longest-standing VCTs — and for a three-decade record of backing consumer, healthcare and technology businesses.

Thesis & focus

Beringea's thesis is patient, transatlantic growth capital: it provides 'patient capital and a global footprint to back founders throughout their journey, helping them overcome barriers to scale and build international success stories.' For founders, the practical edge is expansion support — portfolio companies get help entering the US from the UK and vice versa, drawing on teams that invest in both markets rather than a single home geography.

Sectors & stages

The firm invests across healthcare, technology, media, consumer goods and business services, with current focus areas including enterprise software, marketplaces, medtech and healthcare, consumer and digital health. It targets the early-growth stage — post-product, scaling revenue — rather than pre-seed. Cheques run €1M to €5M+ in Europe, with the US team typically writing $2m–$10m for Series A and growth rounds.

Fund size & cheque size

Beringea manages c. $900m across its UK and US funds. In the UK, the ProVen VCTs alone manage more than £330m across 50+ portfolio companies. VCT capital is evergreen-style and tax-advantaged for UK investors, which gives the UK team durable firepower for follow-on rounds. Founders should note the dual structure: UK deals typically flow through the ProVen VCTs, while US deals run through Beringea's Michigan-based funds.

Beringea funding wins: notable portfolio

The classic UK wins are Monica Vinader — where the ProVen VCTs sold 60% of their holding at a 12x return on original cost — Mergermarket (sold to the FT Group), Watchfinder and Chargemaster. Current holdings on the firm's own site include InvestNext, Gorilla, LITTA, Sovato Health and Papier — a mix of enterprise SaaS, energy data, consumer and health-tech that reflects the sector breadth of the thesis.

Partners & team

The UK investment committee is led by Malcolm Moss, Stuart Veale and Karen McCormick — McCormick is also chief investment officer — with Maria Wagner as a partner in the UK team. In the US, the firm was founded by senior managing director Charlie Rothstein. The partnership's combined venture and private-equity experience runs into many decades, and the firm describes its post-investment style as hands-on support for scaling teams.

How to apply for funding

Beringea runs no online pitch form. Its own guidance to founders is direct: contact the team in the UK at [email protected] or in the US at [email protected], or via the website beringea.com. Come with evidence of scaling traction — Beringea looks for passion, self-awareness and grit in founders, plus a clear route to international growth, which is where its transatlantic platform adds the most value.